Assay for reading six molecular pathways simultaneously developed
Researchers have developed a luciferase assay that can be used to monitor the effects of treatments on six different molecular targets at once.
List view / Grid view
Researchers have developed a luciferase assay that can be used to monitor the effects of treatments on six different molecular targets at once.
New research has categorised hundreds of cancers based on their common protein mutations, highlighting cell components and tumour microenvironments as possible new therapy targets.
A study has demonstrated that dendritic cells play a key role in inflammation and how TNF inhibitors can prevent them from fighting infections.
A new chemical tool has been used to identify hundreds of modified proteins which allows new insights to major diseases.
A group of scientists from India have used 3D imaging of the Nipah virus to discover potential inhibitors for the disease.
Researchers have used ghost imaging to enhance the imaging speed of nanoscopy, which could make it possible to capture processes in living cells at speeds not previously possible.
Scientists have evaluated mouse models used for developing treatments for mood disorders associated with Huntington's disease and have recommended which have greater potential for success.
A study in mice has shown that immunisation against bacterial flagellin could lead to protection from chronic inflammatory diseases.
VTP50469, a new targeted therapy for MLL-rearranged leukaemia, shows greater efficacy and fewer side-effects in mice, according to new research.
Endogenous human antibodies can be used to build and dismantle 2D and 3D DNA nanostructures, finds new research.
A study has demonstrated the success of changing the genome of mice, regulating the production of the C11orf46 gene.
Researchers have found that damage to mitochondria due to sepsis may be the cause of muscle weakness in mice.
Researchers have found that a type of T cell, called a Tr1 cell, could work as a therapeutic strategy for inflammatory bowel disease in children.
A survey has shown that the pharmaceutical industry believes R&D will see a lot of benefit from digital transformation and that AI will be at the forefront.
Researchers have used a machine-learning algorithm to study protein appearance and discover common features that influence function, which could be used to design artificial cells.